|
Re: Crestor / Lipitor - My gut is still telling me we have something.
|
|
Resverlogix Corp.
|
Sep 30, 2019 09:58AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
1
|
Resverlogix Corp.
|
Sep 30, 2019 10:14AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
3
|
Resverlogix Corp.
|
Sep 30, 2019 10:33AM
|
|
Top-Line Results Webcast Transcript 09/30/2019
|
9
|
Resverlogix Corp.
|
Sep 30, 2019 11:41AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
|
Resverlogix Corp.
|
Sep 30, 2019 11:46AM
|
|
Re: Top-Line Results Webcast Transcript 09/30/2019
|
|
Resverlogix Corp.
|
Sep 30, 2019 11:58AM
|
|
Re: Interesting comment from DM
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 12:03PM
|
|
Re: Material information withheld?
|
3
|
Resverlogix Corp.
|
Sep 30, 2019 12:07PM
|
|
NEJM Article: The Primary Outcome Fails — What Next?
|
6
|
Resverlogix Corp.
|
Sep 30, 2019 01:31PM
|
|
Reiterating from ClinicalTrials.gov
|
9
|
Resverlogix Corp.
|
Sep 30, 2019 01:35PM
|
|
Re: Reiterating from ClinicalTrials.gov
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 01:36PM
|
|
Question...glimmers of hope?
|
4
|
Resverlogix Corp.
|
Sep 30, 2019 01:54PM
|
|
Re: NEJM Article: Another possibility it raises
|
3
|
Resverlogix Corp.
|
Sep 30, 2019 02:14PM
|
|
Re: Interesting comment from DM
|
10
|
Resverlogix Corp.
|
Sep 30, 2019 04:09PM
|
|
Re: So BETonMACE failed the primary endpoint. What's next?
|
3
|
Resverlogix Corp.
|
Sep 30, 2019 05:20PM
|
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
7
|
Resverlogix Corp.
|
Oct 07, 2019 08:17AM
|
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
2
|
Resverlogix Corp.
|
Oct 07, 2019 08:24AM
|
|
DocWire
|
3
|
Resverlogix Corp.
|
Oct 18, 2019 07:27AM
|
|
Sorry, not NEJM / Atherosclerosis / Elsevier (eom)
|
3
|
Resverlogix Corp.
|
Oct 18, 2019 08:10AM
|
|
Re: Reply from IR...no surprise, there's nothing there:
|
5
|
Resverlogix Corp.
|
Oct 29, 2019 06:43PM
|
